These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7802310)

  • 1. [A clinical-experimental study of narcotic properties of opiate receptor agonists-antagonists and experience in their use in drug addiction practice].
    Sofronov AG; Kuz'min AV; Pchelintsev MV; Belogurov SB
    Anesteziol Reanimatol; 1994; (4):13-5. PubMed ID: 7802310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D; Koutsogiannis Z; Kronborg I
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New drugs in the group of opiate-antagonistic analgesics].
    Rewerski W; Janicki PK
    Pol Tyg Lek; 1984 Oct; 39(43):1405-8. PubMed ID: 6096836
    [No Abstract]   [Full Text] [Related]  

  • 4. Public policy statement on buprenorphine for opiate dependence and withdrawal.
    J Addict Dis; 2004; 23(4):116-7. PubMed ID: 15534969
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment options for opiate addiction.
    J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews.
    Amato L; Davoli M; Ferri M; Gowing L; Perucci CA
    Drug Alcohol Depend; 2004 Mar; 73(3):219-26. PubMed ID: 15036544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives.
    Wallen MC; Lorman WJ; Gosciniak JL
    J Addict Dis; 2006; 25(1):23-31. PubMed ID: 16597570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Opioid tolerance and dependence--pharmacological aspects].
    Jaba IM; Luncanu I; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(3):444-50. PubMed ID: 12092171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low efficacy of non-opioid drugs in opioid withdrawal symptoms.
    Hermann D; Klages E; Welzel H; Mann K; Croissant B
    Addict Biol; 2005 Jun; 10(2):165-9. PubMed ID: 16191669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing opioid addiction with buprenorphine.
    Donaher PA; Welsh C
    Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using buprenorphine for outpatient opioid detoxification.
    Manlandro JJ
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid dependence: rationale for and efficacy of existing and new treatments.
    Fiellin DA; Friedland GH; Gourevitch MN
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine for office-based treatment of patients with opioid addiction.
    Manlandro JJ
    J Am Osteopath Assoc; 2005 Jun; 105(6 Suppl 3):S8-13. PubMed ID: 16118361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of buprenorphine as a substitute treatment for opiate dependence in the Toxicology Clinics--introductory clinical report].
    Radomska M; Pach J; Chrostek Maj J
    Przegl Lek; 2001; 58(4):351-3. PubMed ID: 11450367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded table: Some drugs for management of opioid withdrawal symptoms.
    Med Lett Drugs Ther; 2018 Aug; 60(1554):e144-e146. PubMed ID: 30133422
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?
    Costa E Silva JA
    Hum Psychopharmacol; 2004 Jun; 19(4):215-24. PubMed ID: 15181649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.